Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
Titel:
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
Auteur:
Ledermann, Jonathan A Oza, Amit M Lorusso, Domenica Aghajanian, Carol Oaknin, Ana Dean, Andrew Colombo, Nicoletta Weberpals, Johanne I Clamp, Andrew R Scambia, Giovanni Leary, Alexandra Holloway, Robert W Gancedo, Margarita Amenedo Fong, Peter C Goh, Jeffrey C O'Malley, David M Armstrong, Deborah K Banerjee, Susana GarcĂa-Donas, Jesus Swisher, Elizabeth M Cameron, Terri Maloney, Lara Goble, Sandra Coleman, Robert L